Clinical trial
Plasma Determination of Glucagon-like Peptide 2 as a Predictor of Recovery in…
NCT00180648 · Imperial College London, Other · Completed
Key facts
| NCT number | NCT00180648 |
|---|---|
| Title | Plasma Determination of Glucagon-like Peptide 2 as a Predictor of Recovery in Adults With Acute Intestinal Failure |
| Official title | Plasma Determination of Glucagon-like Peptide 2 as a Predictor of Recovery in Adults With Acute Intestinal Failure |
| Lead sponsor | Imperial College London, Other |
| Collaborators | Centre for Ocular Research & Education, Canada St Mark's Hospital Foundation |
| Status | Completed |
| Study type | Observational |
| Conditions | Short Bowel Syndrome |
| Enrollment | 30 |
| Start date | Feb 1, 2005 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Sep 16, 2005 |
| Last update posted | Feb 22, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: